Position in AMGN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$187,384,787
+$72,740,447 QoQ
Shares Held
517,466
+58.8% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#91
of 3,131 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swedbank AB holds $5,796,975,204 across 10 Drug Manufacturers - General names. AMGN ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,781,310 | $2,136,556,831 | |
| 2 | JNJ |
Johnson & Johnson
|
3,624,513 | $920,517,565 | |
| 3 | MRK |
Merck & Co., Inc.
|
6,360,649 | $817,343,396 | |
| 4 | ABBV |
AbbVie Inc.
|
2,634,628 | $662,977,789 | |
| 5 | AZN |
Astrazeneca PLC
|
2,241,677 | $425,066,792 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,903,177 | $240,447,381 | |
| 7 | AMGN |
Amgen Inc
This page
|
517,466 | $187,384,787 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,043,205 | $175,349,471 |
All Filings in AMGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $187,384,787 | 517,466 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $114,644,340 | 325,833 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $132,743,516 | 405,559 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $136,980,726 | 485,403 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $214,679,543 | 768,882 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $147,100,263 | 564,381 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $173,638,646 | 538,899 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $166,582,091 | 533,148 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $151,975,012 | 534,527 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $152,255,436 | 528,628 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $141,297,344 | 525,738 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $154,100,973 | 694,086 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $109,054,633 | 451,105 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $135,454,478 | 515,742 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $114,993,219 | 510,174 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $124,111,222 | 510,116 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $122,877,447 | 508,136 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $107,166,709 | 476,360 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $109,694,439 | 515,845 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $124,657,650 | 511,416 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $127,232,476 | 511,364 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||